Notice regarding Conversion of Financial Products
NZX Code: ATM
ASX Code: A2M
24 August 2020
NZX/ASX Market Release
Notice regarding Conversion of Financial Products
For the purposes of NZX Listing Rule 3.15.2 and ASX Listing Rule 3.10.7, The a2 Milk Company (NZX: ATM, ASX: A2M)
provides notice that the following securities have become convertible into fully paid ordinary shares (Ordinary
Shares) in connection with its Long Term Incentive Plan (LTI Plan), and have been converted, as set out below.
No new ordinary shares have been issued in connection with the conversion.
(a) Number of Financial Products converted
and the number and Class of Quoted
Financial Products into which they have
been converted:
94,219 time-based rights converted into 94,219 Ordinary
Shares transferred from the a2MC Group Employee Share Trust
(Share Trust) to a LTI Plan participant. The Ordinary Shares
were acquired on market by the trustee of the Share Trust for
this purpose.
(b) Event giving rise to the right of
conversion:
Issue of a vesting notification from the Board following
satisfaction of the vesting condition, which required the holder
to remain an employee up to and including 24 August 2020.
(c) Details of any interest or dividend
conditions attaching to the Financial
Products into which they have been
converted:
None
(d) Number of Financial Products of the
same Class remaining to be converted:
165,411 time-based rights
(e) Conversion period: From 24 August 2020 to 15 November 2020
(f) Date of conversion: 24 August 2020
The a2 Milk Company Limited
Authorised by Jaron McVicar,
General Counsel and Company Secretary
For further information, please contact:
David Akers
Head of Investor Relations
T +61 2 9697 7013 l M +61 412 944 577
david.akers@a2milk.com
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: Conversion of redeemable preference shares2020-08-07
“Capital Change Notice 7 August 2020 Conversion of redeemable preference shares This notice is given under NZX Listing Rules 3.13.1 and 3.15.2 and relates to the conversion of redeemable preference shares in AFT Pharmaceuticals Limited. Section 1: Issuer information…”
- AFT — AFT Pharmaceuticals Limited: Issue of ordinary shares2020-07-01
“Capital Change Notice 2 July 2020 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in AFT Pharmaceuticals Limited. Section 1: Issuer information Name of issuer AFT Pharmaceuticals Limited NZX t…”
- AFT — AFT Pharmaceuticals Limited: Capital Change Notice – Issue of ordinary shares2020-05-26
“Capital Change Notice AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com 26 May 2020 Issue of ordinary shares This notice is given und…”